Sign In
Buy JNJ
$244.88
+3.88 (+1.61%)
At Close: Jun 25, 2026
Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now
06:10am, Monday, 12'th Feb 2024
If you can identify the right passive income blue-chip stocks, you will be able to enjoy steady income each quarter, and some companies have been rewarding investors for decades. Wouldn't it be nice t
Johnson & Johnson: A High-Quality Dividend King Facing Furious Headwinds
07:00am, Saturday, 10'th Feb 2024
Johnson & Johnson focuses on pharmaceuticals and medical devices after spinning off its consumer-health segment. The company's solid pipeline of cancer, immunology, and neurology drugs, along with its
Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 09'th Feb 2024
Johnson & Johnson (JNJ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income
09:12am, Friday, 09'th Feb 2024
Income-oriented investors often look to dividend stocks to generate a reliable cash flow stream. However, not all dividend payers are created equal.
3 Dividend Stocks to Cling to This Year
06:30am, Friday, 09'th Feb 2024
If you are here to build a portfolio that thrives in all seasons, consider dividend stocks. They can generate steady returns and provide stability to your investments.
J&J, Merck and Bristol Myers CEOs, under fire on Capitol Hill, seek to turn up heat on drug-market middlemen
03:29pm, Thursday, 08'th Feb 2024
Drugmakers grilled on the cost of prescription drugs on Capitol Hill Thursday sought to deflect the criticism onto drug-market middlemen who they said are pushing list prices for medications higher.
US Senate Democrats grill pharma CEOs on drug prices
03:18pm, Thursday, 08'th Feb 2024
U.S. Senate Democrats grilled three top pharmaceutical executives over the high cost of prescription drugs on Thursday but failed to extract any commitments from them to lower prices.
Pharma CEOs Will Testify Today Over Prescription Drug Prices: Here's What To Watch For
10:28am, Thursday, 08'th Feb 2024
Chief executives from three major pharmaceutical companies will testify before a Senate committee on Thursday, following a back-and-forth with Sen. Bernie Sanders (I-Vt.
J&J spinoff Kenvue stock loses ground as profit drops
07:41am, Thursday, 08'th Feb 2024
Kenvue Inc.'s stock KVUE, -0.39% fell by 3.2% in premarket trading on Thursday after the household products spin-off of Johnson & Johnson JNJ, -0.05% reported lower fourth-quarter profit and said its
Senators to question Merck, J&J and Bristol Myers Squibb CEOs over high U.S. drug pricing
07:00am, Thursday, 08'th Feb 2024
The push to cut drug prices is one of those rare hot-button issues that unites the two major political parties.
Is Johnson & Johnson a Good Dividend Stock to Buy Now?
05:37am, Thursday, 08'th Feb 2024
Shares of Johnson & Johnson offer a 3% dividend yield and the confidence that comes with 61 consecutive years of annual dividend raises. Last year, Johnson & Johnson spun off its consumer health divis
5 Dividend Aristocrats Signal Buy In February And 6 To Watch
05:26pm, Wednesday, 07'th Feb 2024
"Dividend Aristocrats. in the S&P 500 Index… have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com. 67 Aristocrats, screened as of February 5, 2024 represen
Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill, but experts cite deeper problems under the radar
02:08pm, Wednesday, 07'th Feb 2024
Lawmakers seeking to hold drugmakers accountable for high prescription-drug costs are focusing on some prices that shed little light on the problem, drug-pricing experts say.
Is Johnson & Johnson Stock a Buy Now?
05:25am, Wednesday, 07'th Feb 2024
Johnson & Johnson has a massive footprint in healthcare, even after spinning off its consumer products segment. Fantastic financials give the company lots of flexibility to acquire growing assets stra
J&J Accused of Mismanaging Its Employees' Drug Benefits
03:42pm, Monday, 05'th Feb 2024
The novel lawsuit by a J&J worker alleges employees overpaid for some drugs.
